4Molina CA,Montaner J,Abilieira S,et al.Timing of spontaneous recanalization and risk of hemorrhagic transformation in acute cardioe mbolic stroke[J].Stroke,2001,32(5):1079-1084.
6Toni D,Fiorelli M,Bastianello S,et al. hemorrhagic transformation of brain infarct;predictability in the first five hours frome stroke onset and influence on clinical outcome [J].Neurology,1996,46(2):341-345.
7Bozzao L,Angeloni U,Bastianello S,et al.Early angiographic and CT finding in patients with hemorrhagic transformation in the distribution of the middle cerebral artery[J].America Journal of Neuroradiology,1991,12(6):1115-1121.
8Schwamm LH,Rosenthal ES, Swap CJ.et al.Hypoattenuation on CT angiographic source images predicts risk of intracerebral hemorrhage and outcome after intra-arterial reperfusiontherapy[J].America Journal of Neuroradiology,2005,26(7):1798-1803.
9Hayman LA,Evans RA,Bastion FO,et al.Delayed high dose contrast CT;identifying patients at risk of massive hemorrhagic transformation[J].American Journal of Roentgenology,1981,136(6):1151-1159.
10Knight RA,Barker PB,Fagan SC,et al.prediction of impending hemorrhagic transformation in ischemic stroke using magnetic resenance imaging in rats [J].Stroke,1998,29(1):144-151.
4[1]Ross R.The pathogenesis of atherosclerosis:A perspective for the 1990s.Nature,1993,362:801-808.
5[2]Libby P.Changing concepts of atherogenesis.J Intern Med,2000,247:349-358.
6[3]Loftus I,Naylor R,goodall S,et al.Increased matrix metalloproteinase-9 activity in unstable carotid plaques.A potential role in acute plaque disruption.Stroke,2000,31:40-47.
7[7]Lichtinghagen R,Huegel O,Seifert T,et al.Expression of matrix metalloproteinase-2 and-9 and their inhibitors in peripheral blood cells of patients with chronic hepatitis C.Clin Chem,2000,46:183-192.
8[8]Lichtinghagen R,Seifert T,Kracke A,et al.Expression of matrix metalloproteinase-9 and its inhibitors in mononuclear blood cells of patients with multiple sclerosis.J Neuroimmunol,1999,99:19-26.
9[9]Criqui MN,Denenberg JO.The generalized nature of atherosclerosis:How peripheral arterial disease may predict adverse events from coronary artery disease.Vasc Med,1998,3:241-245.
10[10]Altieri P,Brunelli C,Garibaldi S,et al.Metalloproteinases 2 and 9 are increased in plasma of patients with heart failure.Eur J Clin Invest,2003,33:648-656.
